Automated Stress Detection and Restoration in Office Workers

July 7, 2022 updated by: Burcin Becerik-Gerber, University of Southern California
This study aims at establishing a laboratory experiment that mimics office work stressors, examining the feasibility of automated stress detection, and identifying the most significant physiological and/or behavioral features that can be used to differentiate between positive stress (eustress) and negative stress (distress). Additionally, we will investigate if triggering the olfactory (exposing participants to pleasant smells) senses would help reduce stress.

Study Overview

Status

Completed

Conditions

Detailed Description

The experiment is divided into 2 main phases:

The first phase is the eustress-distress data collection: In this phase, participants will complete three conditions:

  1. "No-stress": Participants will sit idle on their desks without performing any task. This is important to record a baseline of physiological signals that will allow us to compare the physiological responses in later stages.
  2. "Low-stress work": Participants will be asked to prepare a brief presentation about a familiar topic (e.g., favorite types of food, TV shows, academic work). A strict time limit will not be provided; instead, participants will be told that they have at least 30 minutes and up to 40 minutes if they need that amount of time to complete the presentation.
  3. "High-stress work": Participants will be required to prepare a presentation about an unfamiliar topic with a time limit of 30 minutes. The topic and the requirements will be carefully established to make the completion of the presentation achievable but at the same time to create a sense of time pressure, heavy workload, and unfamiliarity with the task. We will employ a concept similar to the Trier Social Stress Test, in which participants are required to develop and deliver a speech to a panel. This test has been employed in several studies as a means of inducing high-stress reactions. In our study, participants will be informed that a two-person judging committee will be scoring their work performance by watching through a Zoom shared screen. Participants will be told that their final score will be compared to all other study participants such that the highest scoring individuals will receive an award. The committee's "score" will be presented on the screen beginning at 100 and will be decreased and increased in a standardized manner across all participants. Changes in the score will appear at uneven intervals such that the participants do not recognize a pattern but associate the scoring with the judging committee noticing some sort of work flaw or issue. A countdown clock with time remaining will be presented on the screen, recorded office noise (e.g., printers, distant chatting, computers) will be played in the background, and temperature will be increased outside the comfort range. In addition, participants will be subject to interruptions including pop-up messages, calls or emails every 5 minutes to ask about progress.

During the three conditions (idle, low stress, high stress) participants will be asked 5 questions every 5 minutes:

  1. In the last five minutes, to what extent did you consider the work you are performing as an opportunity or challenge?
  2. In the last five minutes, to what extent did you consider the work you are performing as a source of pressure?
  3. Over the last five minutes, how would you rate your productivity?
  4. Over the last five minutes, how would you rate your mood?
  5. Over the last five minutes, how would you rate your stress level?

The second phase is meant to investigate if triggering the olfactory (exposing participants to pleasant smells) senses would help reduce stress.

For that, participants will be given a task that an office worker usually conducts in their everyday work (e.g., typing a paragraph in a word document, organizing a spreadsheet) for 20 minutes. During the 20 minutes, participants will get exposed to one of the following three conditions:

  1. Control group - 20 participants: No exposure to smells or change in office light settings.
  2. Olfactory group 1 - 20 participants: No change in office light settings, but participants in this condition will be exposed to the smell of natural wood scent continuously. A diffuser with essential oils will be turned on during that time to deliver the smell.
  3. Olfactory group 2 - 20 participants: No change in office light settings, but participants in this condition will be exposed to the smell of Bergamot scent continuously. A diffuser with essential oils will be turned on during that time to deliver the smell.

Following this, participants will be asked to rate their anxiety/stress levels using the state anxiety trait survey and how they perceived the exposure to the scents.

Study Type

Interventional

Enrollment (Actual)

50

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • California
      • Los Angeles, California, United States, 90089
        • University of Southern California

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. Participants will be older than 18.
  2. Participants should be proficient at speaking and writing in English.
  3. Qualified participants should have a normal or corrected-to-normal vision, and a normal sense of smell.

Exclusion Criteria:

  1. Participants will be screened to make sure that they don't have any physical or psychological-related problems that make them sensitive to stress-inducing tasks.
  2. Participants who are taking any medication to regulate their blood pressure will not be allowed to participate in the study as these medications might affect the quality of the blood volume pulse-related data.
  3. Pregnant women are not allowed to participate in this study.
  4. Participants using prescription medication, diagnosed with color blindness, rhinitis, or hay fever, or have allergic reactions to essential oils ( e.g., contact dermatitis, allergic rhinitis) will not be allowed to participate in this study.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Diagnostic
  • Allocation: Randomized
  • Interventional Model: Factorial Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Control
No exposure to smells.
Experimental: Olfactory Condition - 1
Participants in this condition will be exposed to the smell of natural wood scent continuously. A diffuser with essential oils will be turned on during that time to deliver the smell.
Wood notes tend to be rich and warm, often forming the base of a scent due to their aromatic weight.
Experimental: Olfactory Condition - 2
Participants in this condition will be exposed to the smell of Bergamot scent continuously. A diffuser with essential oils will be turned on during that time to deliver the smell.
The scent of bergamot is fruity and citrusy, with floral hints and spice notes.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Heart rate
Time Frame: Throughout study participation, up to 120 minutes
Heart rate will be collected through a sensor attached to the participant's chest at a collection rate of 1 heart rate reading per second. The average heart rate will be examined across study conditions.
Throughout study participation, up to 120 minutes
Electrodermal activity
Time Frame: Throughout study participation, up to 120 minutes
Electrodermal activity will be collected through a sensor placed on the wrist similar to a watch, with data collection at a rate of 4 readings per second. The average electrodermal activity will be examined across study conditions.
Throughout study participation, up to 120 minutes
Blink rate
Time Frame: Throughout study participation, up to 120 minutes
A facial detection algorithm will be used to detect the blinking rate of the participant from a camera that collects 10 frames per second. The average blink rate will be examined across study conditions.
Throughout study participation, up to 120 minutes
Gaze angle
Time Frame: Throughout study participation, up to 120 minutes
A facial detection algorithm will be used to detect the gaze angle direction of the participant from a camera that collects 10 frames per second. The durations of gaze angles will be examined across study conditions.
Throughout study participation, up to 120 minutes

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Mouse clicks
Time Frame: Throughout study participation, up to 120 minutes
The number of mouse clicks will be recorded using a logger software installed on the computer. The frequency of mouse clicks will be examined across study conditions.
Throughout study participation, up to 120 minutes
Keyboard keystrokes
Time Frame: Throughout study participation, up to 120 minutes
The number of keystrokes will be recorded using a logger software installed on the computer. The frequency of keystrokes will be examined across study conditions.
Throughout study participation, up to 120 minutes

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Burcin Becerik-Gerber, PhD, University of Southern California

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 1, 2022

Primary Completion (Actual)

July 5, 2022

Study Completion (Actual)

July 5, 2022

Study Registration Dates

First Submitted

January 20, 2022

First Submitted That Met QC Criteria

February 4, 2022

First Posted (Actual)

February 16, 2022

Study Record Updates

Last Update Posted (Actual)

July 8, 2022

Last Update Submitted That Met QC Criteria

July 7, 2022

Last Verified

July 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • UP-21-00484

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Stress

Clinical Trials on Natural wood scent

Subscribe